ABVC BIOPHARMA INC (ABVC)
US00091F3047 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 360K -25.00% | 970K 169.44% | 152.43K -84.29% | -100.00% | 4.256M | |
| EBITDA YoY % growth | -11.7M -38.13% | -15.09M -28.97% | -8.188M 45.74% | N/A | N/A | |
| EBIT YoY % growth | -11.71M -37.60% | -15.11M -29.04% | -8.217M 45.62% | -17.51M -113.11% | -19.358M -10.55% | |
| Operating Margin | -3,252.78% | -1,557.73% | -5,390.35% | N/A | -454.83% | |
| EPS YoY % growth | N/A 32.35% | N/A -126.09% | N/A 94.62% | -0.45 -57.14% | -0.47 -4.55% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 96.60% | -0.05 | % | |
| Q3 2023 Q2Q % growth | 96.29% | -0.04 | % | |
| Q2 2023 Q2Q % growth | -0.68 -13.33% | -0.06 | -0.62 | -1,011.11% |
| Q1 2023 Q2Q % growth | -0.60 -900.00% | -0.51 | -0.09 | -17.65% |
| Q4 2022 Q2Q % growth | -1.50 51.61% | -1.53 | 0.03 | 1.96% |
| Q3 2022 Q2Q % growth | -1.10 -1,471.43% | -1.28 | 0.17 | 13.73% |
| Q2 2022 Q2Q % growth | -0.60 -650.00% | -1.28 | 0.67 | 52.94% |
| Q1 2022 Q2Q % growth | -0.06 | -0.20 | 0.14 | 70.59% |
| Q4 2021 Q2Q % growth | -3.10 -1,191.67% | -0.41 | -2.69 | -659.80% |
| Q3 2021 Q2Q % growth | -0.07 | -0.04 | -0.03 | -71.57% |
| Q4 2020 Q2Q % growth | -0.24 | -0.10 | -0.14 | -135.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 389.28K 2,351.39% | % | ||
| Q2 2024 Q2Q % growth | 117.14K 1,071.40% | % | ||
| Q1 2024 Q2Q % growth | 1.21K -99.06% | % | ||
| Q4 2023 Q2Q % growth | 2.17K -99.63% | 714K | -711.83K | -99.70% |
| Q3 2023 Q2Q % growth | 15.88K -60.30% | 15.88K | % | |
| Q2 2023 Q2Q % growth | 10K -96.77% | 306K | -296K | -96.73% |
| Q1 2023 Q2Q % growth | 128.27K 327.57% | 128.27K | % | |
| Q4 2022 Q2Q % growth | 590K 1,575.00% | 13.26K | 576.74K | 4,349.47% |
| Q3 2022 Q2Q % growth | 40K -60.00% | 13.26K | 26.74K | 201.66% |
| Q2 2022 Q2Q % growth | 310K 933.33% | 13.26K | 296.74K | 2,237.86% |
| Q1 2022 Q2Q % growth | 30K -88.46% | 26.52K | 3.48K | 13.12% |
| Q4 2021 Q2Q % growth | -40K -166.67% | 198.9K | -238.9K | -120.11% |
| Q3 2021 Q2Q % growth | 100K -16.67% | 146.88K | -46.88K | -31.92% |
| Q2 2021 Q2Q % growth | 30K -86.96% | % | ||
| Q1 2021 Q2Q % growth | 260K 225.00% | % | ||
| Q4 2020 Q2Q % growth | 60K -40.00% | 118.32K | -58.32K | -49.29% |
| Q3 2020 Q2Q % growth | 120K -40.00% | % | ||
| Q2 2020 Q2Q % growth | 230K 21.05% | % | ||
| Q1 2020 Q2Q % growth | 80K -61.90% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |